-
N6-methyladenosine (N6-甲基腺苷, m6A) is a modification formed by adding a methyl group (-CH3) to the sixth nitrogen atom of adenosine.
-
Ritadex is a 39-amino acid polypeptide drug that belongs to the triple receptor agonists of GLP-1R/GIPR/GCGR.
-
Teriparatide is a recombinant parathyroid hormone (PTH) fragment (PTH 1-34) composed of 34 amino acids, and its mechanism of action is mainly regulated by the activation of the PTH1 receptor (PTH1R)
-
The pharmacokinetic properties of tirzepatide, a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist, are essential for understanding its behavior and role in vivo.
-
γ-Synuclein is a 127-amino acid protein with a molecular weight of approximately 13.3 kDa. Structurally, it belongs to the class of intrinsically disordered proteins (IDPs), which lack stable secondary or tertiary structures under physiological conditions.
-
Among the six alternative splicing isoforms of human Tau, Tau441 (also called 2N4R Tau) is the longest form, containing 441 amino acids with two N-terminal inserts and four microtubule-binding repeat domains.
-
Anti-dsRNA antibodies have become indispensable tools in basic RNA research, enabling scientists to explore the dynamic roles of dsRNA in virus-host interactions, immune signaling pathways, and RNA metabolism.
-
This article reviews the biological functions of CDX-2, details the current applications of anti-CDX-2 monoclonal antibodies in research and clinical practice, and explores their future development prospects.
-
The anti-IBA1/AIF1 monoclonal antibody is an immunodetection tool that specifically recognizes IBA1/AIF1. This article systematically reviews its applications in neurodegenerative diseases, tumor immunology, autoimmune diseases, and transplant rejection, while discussing its potential in precision m
-
Isotype control antibodies are essential negative control tools widely employed across immunoassays, including flow cytometry, immunohistochemistry (IHC), and immunofluorescence (IF).